Edgewise Therapeutics, Inc. (EWTX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch EWTX
See up to 3 months of EWTX. The 7-day demo opens the 1M and 3M ranges and puts EWTX on your watchlist.
Start 7-day demoLatest EWTX insider trades
About Edgewise Therapeutics, Inc. (EWTX)
The SEC lists Edgewise Therapeutics, Inc. under CIK 0001710072, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
EWTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 19 | 43,429 | $1.90M |
| Grant or award | 19 | 1,176,060 | |
| Option exercise | 20 | 182,496 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
EWTX insider transactions (Form 4)
10648 Form 4 filings on record, the earliest from Oct 16, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jonathan C. Fox - Director | Grant or award | Common Stock | 308 | $0.00 | - | |
| Michael Nofi - Officer | Grant or award | Stock Option (Right to Buy) | 48,750 | $0.00 | - | |
| Joanne M. Donovan - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Alan J. Russell - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
 John R. Moore - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| Behrad Derakhshan - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Michael Nofi - Officer | Grant or award | Restricted Stock Units | 24,375 | $0.00 | - | |
| Michael Nofi - Officer | Grant or award | Stock Option (Right to Buy) | 48,750 | $0.00 | - | |
| Joanne M. Donovan - Officer | Option exercise | Common Stock | 5,781 | $0.00 | - | |
| Joanne M. Donovan - Officer | Option exercise | Common Stock | 7,031 | $0.00 | - | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 2,839 footnote F2 | $43.78 footnote F3 | $124K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 2,779 footnote F2 | $43.71 footnote F4 | $121K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 104 footnote F2 | $44.43 footnote F5 | $5K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 800 footnote F2 | $44.52 footnote F6 | $36K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 2,919 footnote F7 | $43.41 footnote F8 | $127K | |
| Joanne M. Donovan - Officer | Option exercise | Restricted Stock Units | 5,781 | $0.00 | - | |
| Joanne M. Donovan - Officer | Option exercise | Restricted Stock Units | 7,031 | $0.00 | - | |
| Joanne M. Donovan - Officer | Grant or award | Restricted Stock Units | 32,500 | $0.00 | - | |
| Joanne M. Donovan - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| ||||||
| Alan J. Russell - Officer | Open-market sale | Common Stock | 390 footnote F1 | $44.46 | $17K | |
| Alan J. Russell - Officer | Option exercise | Common Stock | 5,781 | $0.00 | - | |
| Alan J. Russell - Officer | Option exercise | Common Stock | 7,031 | $0.00 | - | |
| Alan J. Russell - Officer | Open-market sale | Common Stock | 3,238 footnote F1 | $43.68 footnote F2 | $141K | |
| Alan J. Russell - Officer | Open-market sale | Common Stock | 2,273 footnote F1 | $43.68 footnote F3 | $99K | |
| Alan J. Russell - Officer | Option exercise | Restricted Stock Units | 5,781 | $0.00 | - | |
| Alan J. Russell - Officer | Option exercise | Restricted Stock Units | 7,031 | $0.00 | - | |
| Alan J. Russell - Officer | Grant or award | Restricted Stock Units | 32,500 | $0.00 | - | |
| Alan J. Russell - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| ||||||
| John R. Moore - Officer | Option exercise | Common Stock | 5,781 | $0.00 | - | |
| John R. Moore - Officer | Option exercise | Common Stock | 6,718 | $0.00 | - | |
| John R. Moore - Officer | Open-market sale | Common Stock | 2,439 footnote F1 | $43.81 footnote F2 | $107K | |
| John R. Moore - Officer | Open-market sale | Common Stock | 59 footnote F1 | $44.41 footnote F3 | $3K | |
| John R. Moore - Officer | Open-market sale | Common Stock | 99 footnote F1 | $44.50 footnote F4 | $4K | |
| John R. Moore - Officer | Open-market sale | Common Stock | 2,419 footnote F1 | $43.80 footnote F5 | $106K | |
| John R. Moore - Officer | Option exercise | Restricted Stock Units | 5,781 | $0.00 | - | |
| John R. Moore - Officer | Option exercise | Restricted Stock Units | 6,718 | $0.00 | - | |
| John R. Moore - Officer | Grant or award | Restricted Stock Units | 32,500 | $0.00 | - | |
| John R. Moore - Officer | Grant or award | Stock Option (Right to Buy) | 65,000 | $0.00 | - | |
| ||||||
| Behrad Derakhshan - Officer | Option exercise | Common Stock | 5,781 | $0.00 | - | |
| Behrad Derakhshan - Officer | Option exercise | Common Stock | 7,500 | $0.00 | - | |
| Behrad Derakhshan - Officer | Open-market sale | Common Stock | 2,171 footnote F1 | $43.79 footnote F2 | $95K | |
| Behrad Derakhshan - Officer | Open-market sale | Common Stock | 304 footnote F1 | $44.50 footnote F3 | $14K | |
| Behrad Derakhshan - Officer | Open-market sale | Common Stock | 150 footnote F1 | $44.44 footnote F4 | $7K | |
| Behrad Derakhshan - Officer | Open-market sale | Common Stock | 2,475 footnote F1 | $43.70 footnote F5 | $108K | |
| Behrad Derakhshan - Officer | Option exercise | Restricted Stock Units | 5,781 | $0.00 | - | |
| Behrad Derakhshan - Officer | Option exercise | Restricted Stock Units | 7,500 | $0.00 | - | |
| Behrad Derakhshan - Officer | Grant or award | Restricted Stock Units | 50,000 | $0.00 | - | |
| Behrad Derakhshan - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| ||||||
| Kevin Koch - Officer | Option exercise | Common Stock | 17,969 | $0.00 | - | |
| Kevin Koch - Officer | Option exercise | Common Stock | 21,875 | $0.00 | - | |
| Kevin Koch - Officer | Open-market sale | Common Stock | 8,782 footnote F1 | $43.64 footnote F2 | $383K | |
| Kevin Koch - Officer | Open-market sale | Common Stock | 8,276 footnote F1 | $43.66 footnote F3 | $361K | |
| Kevin Koch - Officer | Open-market sale | Common Stock | 913 footnote F1 | $44.33 footnote F4 | $40K | |
| Kevin Koch - Officer | Option exercise | Restricted Stock Units | 17,969 | $0.00 | - | |
| Kevin Koch - Officer | Option exercise | Restricted Stock Units | 21,875 | $0.00 | - | |
| Kevin Koch - Officer | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Kevin Koch - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| ||||||
| Jonathan D. Root - Director | Grant or award | Stock Option (Right to Buy) | 16,377 | $0.00 | - | |
| Alan J. Russell - Officer | Option exercise | Common Stock | 130,352 | $0.45 | $59K | |
| Alan J. Russell - Officer | Option exercise | Common Stock | 69,648 | $0.18 | $13K | |
| Alan J. Russell - Officer | Open-market sale | Common Stock | 130,352 | $39.41 footnote F2 | $5.14M | |
| Alan J. Russell - Officer | Open-market sale | Common Stock | 69,648 | $39.41 footnote F3 | $2.74M | |
| Alan J. Russell - Officer | Option exercise | Stock Option (Right to Buy) | 130,352 | $0.00 | - | |
| Alan J. Russell - Officer | Option exercise | Stock Option (Right to Buy) | 69,648 | $0.00 | - | |
| ||||||
| Jonathan C. Fox | Grant or award | Common Stock | 319 | $0.00 | - | |
| Laura Brege | Grant or award | Stock Option (Right to Buy) | 16,377 | $0.00 | - | |
 Peter A. Thompson | Grant or award | Stock Option (Right to Buy) | 16,377 | $0.00 | - | |
| Arlene Morris | Grant or award | Stock Option (Right to Buy) | 16,377 | $0.00 | - | |
| Badreddin Edris | Grant or award | Stock Option (Right to Buy) | 8,188 | $0.00 | - | |
| Badreddin Edris | Grant or award | Restricted Stock Units | 5,619 | $0.00 | - | |
| Christopher Nathan Martin | Grant or award | Stock Options (Right to buy) | 16,377 | $0.00 | - | |
| Jonathan C. Fox | Grant or award | Stock Option (Right to Buy) | 16,377 | $0.00 | - | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 5,230 footnote F1 | $31.29 footnote F2 | $164K | |
| Joanne M. Donovan - Officer | Option exercise | Common Stock | 50,000 | $7.08 | $354K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 50,000 footnote F1 | $38.57 footnote F3 | $1.93M | |
| Joanne M. Donovan - Officer | Option exercise | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| ||||||
| Jonathan C. Fox | Grant or award | Common Stock | 339 | $0.00 | - | |
| Joanne M. Donovan - Officer | Option exercise | Common Stock | 28,662 | $7.08 | $203K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 28,662 | $32.31 footnote F2 | $926K | |
| Joanne M. Donovan - Officer | Option exercise | Stock Option (Right to Buy) | 28,662 | $0.00 | - | |
| ||||||
| Joanne M. Donovan - Officer | Option exercise | Common Stock | 21,338 | $7.08 | $151K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 21,338 | $32.12 footnote F2 | $685K | |
| Joanne M. Donovan - Officer | Option exercise | Stock Option (Right to Buy) | 21,338 | $0.00 | - | |
| ||||||
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 9,623 footnote F1 | $30.98 footnote F2 | $298K | |
| Joanne M. Donovan - Officer | Open-market sale | Common Stock | 6,735 | $30.98 footnote F2 | $209K | |
| ||||||
| Badreddin Edris | Option exercise | Common Stock | 13,690 | $0.39 | $5K | |
| Badreddin Edris | Option exercise | Common Stock | 17,236 | $0.64 | $11K | |
| Badreddin Edris | Option exercise | Common Stock | 10,463 | $1.93 | $20K | |
| Badreddin Edris | Option exercise | Common Stock | 66,477 | $1.93 | $128K | |
| Badreddin Edris | Option exercise | Common Stock | 7,605 | $0.71 | $5K | |
| Badreddin Edris | Option exercise | Stock Option (Right to Buy) | 10,463 | $0.00 | - | |
| Badreddin Edris | Option exercise | Stock Option (Right to Buy) | 66,477 | $0.00 | - | |
| Badreddin Edris | Option exercise | Stock Option (Right to Buy) | 7,605 | $0.00 | - | |
| Badreddin Edris | Open-market sale | Common Stock | 13,690 | $29.44 footnote F2 | $403K | |
| Badreddin Edris | Open-market sale | Common Stock | 17,236 | $29.44 footnote F2 | $507K | |
| Badreddin Edris | Option exercise | Stock Option (Right to Buy) | 17,236 | $0.00 | - | |
| Badreddin Edris | Option exercise | Stock Option (Right to Buy) | 13,690 | $0.00 | - | |
| Badreddin Edris | Open-market sale | Common Stock | 7,605 | $29.44 footnote F2 | $224K | |
| Badreddin Edris | Open-market sale | Common Stock | 10,463 | $29.44 footnote F2 | $308K | |
| Badreddin Edris | Open-market sale | Common Stock | 66,477 | $29.44 footnote F2 | $1.96M | |
| ||||||
| Christopher Nathan Martin | Grant or award | Stock Options (Right to buy) | 45,150 | $0.00 | - | |
| Alan J. Russell - Officer | Option exercise | Common Stock | 100,000 | $0.18 | $18K | |
| Alan J. Russell - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Alan J. Russell - Officer | Open-market sale | Common Stock | 100,000 | $21.12 footnote F1 | $2.11M | |
| ||||||
| Michael Nofi - Officer | Grant or award | Restricted Stock Units | 43,750 | $0.00 | - | |
| Michael Nofi - Officer | Grant or award | Stock Options (Right to buy) | 262,500 | $0.00 | - | |
Item 2.02, 9.01
Item 9.01
Item 2.01, 7.01, 9.01
Item 5.07
Recent EWTX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JOANNE DONOVAN | Officer | 2,919 | $127K | View on EDGAR | |
| - | - | - | - |
EWTX insider trading FAQ
What is the latest insider trade for EWTX?
Edgewise Therapeutics, Inc. (EWTX) had 13 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for EWTX runs to 48 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EWTX stock?
No insider purchases of EWTX were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling EWTX stock?
19 insider sales of EWTX were filed in the last 90 days, totaling $1.90M.
Where can I see EWTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EWTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jonathan C. Fox view on EDGAR
- - Michael Nofi view on EDGAR
- - Joanne M. Donovan view on EDGAR
- - Alan J. Russell view on EDGAR
- - John R. Moore view on EDGAR
- - Behrad Derakhshan view on EDGAR
- - Michael Nofi view on EDGAR
- - Joanne M. Donovan view on EDGAR
- - Alan J. Russell view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where EWTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EWTX with a 7-day demo
- EWTX on your watchlist
- Every EWTX Form 4 filing on record
- Up to 3 months of EWTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
